Logo

American Heart Association

  2
  0


Final ID: TP305

Prevalence and Predictors of Post-Stroke Anxiety and Depression

Abstract Body: Introduction: Acute ischemic stroke (AIS) may be associated with feelings of anxiety and/or depression (A/D) in subsequent months. The purpose of this study was to determine the frequency of feelings of A/D after AIS longitudinally and to identify risk factors that may predict post-stroke feelings of A/D.

Methods: Data were collected from patients with AIS at a stroke center from 2016-2022. Patients were excluded if <18 years old, did not fill out the EQ-5D, or who were deceased or designated as comfort measures only upon hospital discharge. Patient demographics, medical history, stroke anatomic location, and pre-morbid modified Rankin score, a score of functional status, were collected during hospital admission. A/D was the outcome of interest and was collected via the self-reported EQ-5D. It is scored from 1-3, with 1 indicating no perceived problems, 2 indicating feelings of being moderately anxious or depressed, and 3 indicating feelings of being extremely anxious or depressed. Scores were dichotomized with a score of 1 representing no feelings of A/D and a score of 2 or 3 indicating any feelings of A/D. We built a multivariate logistic regression model using the collected covariates to predict the odds of feelings of A/D 3-months post-stroke.

Results: The cohort was 1,225 patients. The prevalence of feelings of A/D was 38.7% at 3-months after stroke. Compared to those without feelings of A/D at 3-months, patients with feelings of A/D were more frequently female (56.5% vs 43.14%, p<0.0001), Hispanic (9.8% vs 5.5%, p=0.014), had NIHSS > 10 (33.7% vs 24.4%, p=0.0006), had prior stroke (22.1% vs 16.6%, p=0.025), and had a history of drug use (12.4% vs 8.2%, p=0.0486). In the adjusted multivariate model, female sex (OR 1.76, 95% CI 1.27-2.43), non-White race (OR 1.21, 95% CI 1.04-1.41), Hispanic ethnicity (OR 1.87, 95% CI 1.05-3.36), absence of atrial fibrillation (OR 1.79, 95% CI 1.08-3.03), anticoagulation use (OR 2.04, 95% CI 1.18-3.57), and statin non-use (OR 1.59, 95% CI 1.09-2.34) were significant, independent predictors of feelings of A/D at 3-months post-stroke.

Conclusions: Over one in three patients experience feelings of A/D at 3-months after stroke. We identified predictors of feelings of A/D at 3-months post-stroke. Our findings are hypothesis-generating and require further study. Understanding the factors that may predispose patients to have feelings of A/D post-stroke may enhance screening efforts, particularly in these high-risk groups.
  • Mcnamara, Katelyn  ( Yale School of Medicine , Hamden , Connecticut , United States )
  • Shah, Dipti  ( Yale School of Medicine , Hamden , Connecticut , United States )
  • Forman, Rachel  ( Yale School of Medicine , Hamden , Connecticut , United States )
  • Falcone, Guido  ( Yale School of Medicine , Hamden , Connecticut , United States )
  • Sheth, Kevin  ( Yale School of Medicine , Hamden , Connecticut , United States )
  • Sansing, Lauren  ( Yale School of Medicine , Hamden , Connecticut , United States )
  • Pittenger, Christopher  ( Yale School of Medicine , New Haven , Connecticut , United States )
  • Sharma, Richa  ( Yale School of Medicine , Hamden , Connecticut , United States )
  • White, Milo  ( Yale School of Medicine , Hamden , Connecticut , United States )
  • Peyravi, Reza  ( Yale School of Medicine , Hamden , Connecticut , United States )
  • Zubair, Adeel  ( Yale School of Medicine , Hamden , Connecticut , United States )
  • Driskell, Lucas  ( Yale School of Medicine , Hamden , Connecticut , United States )
  • Fesharaki-zadeh, Arman  ( Yale School of Medicine , New Haven , Connecticut , United States )
  • Leary, Megan  ( Yale School of Medicine , Hamden , Connecticut , United States )
  • Torres Lopez, Victor  ( Yale School of Medicine , Hamden , Connecticut , United States )
  • Kampp, Michael  ( Yale School of Medicine , Hamden , Connecticut , United States )
  • Author Disclosures:
    Katelyn McNamara: DO NOT have relevant financial relationships | Dipti Shah: DO NOT have relevant financial relationships | Rachel Forman: DO NOT have relevant financial relationships | Guido Falcone: DO NOT have relevant financial relationships | Kevin Sheth: DO NOT have relevant financial relationships | Lauren Sansing: DO NOT have relevant financial relationships | Christopher Pittenger: DO have relevant financial relationships ; Consultant:Biohaven Pharmaceuticals:Active (exists now) ; Consultant:UCB BioPharma:Past (completed) ; Consultant:F-prime Capital Partners:Past (completed) ; Research Funding (PI or named investigator):Freedom Biosciences:Active (exists now) ; Consultant:Freedom Biosciences:Active (exists now) ; Advisor:Lucid/care:Active (exists now) ; Ownership Interest:Lucid/care:Active (exists now) ; Advisor:Mind Therapeutics:Active (exists now) ; Ownership Interest:Mind Therapeutics:Active (exists now) ; Ownership Interest:Alco Therapeutics:Active (exists now) ; Research Funding (PI or named investigator):Biohaven Pharmaceuticals:Active (exists now) | Richa Sharma: DO NOT have relevant financial relationships | Milo White: No Answer | Reza Peyravi: No Answer | Adeel Zubair: DO NOT have relevant financial relationships | Lucas Driskell: DO NOT have relevant financial relationships | Arman Fesharaki-Zadeh: No Answer | Megan Leary: DO NOT have relevant financial relationships | Victor Torres Lopez: DO NOT have relevant financial relationships | Michael Kampp: No Answer
Meeting Info:
Session Info:

Risk Factors and Prevention Posters II

Thursday, 02/06/2025 , 07:00PM - 07:30PM

Poster Abstract Session

More abstracts on this topic:
A Comparison of Anxiety and Depression in Patients with Symptoms of Palpitations Compared to High Risk Arrythmia Patients.

Treuth Mark, Patel Kunnal, Rissmiller Justin, Holdai Veera

Association of Depression and Anxiety with Coronary Plaque: The Miami Heart Study (MiHeart)

Bafna Tanvi, Blaha Michael, Dzaye Omar, Dardari Zeina, Cainzos Miguel, Blankstein Ron, Feldman Theodore, Budoff Matthew, Fialkow Jonathan, Nasir Khurram

More abstracts from these authors:
Integrated Genomic and Proteomic Profiling Support Cathepsin-B as a Drug Repurposing Target in Cerebral Small Vessel Disease

Rivier Cyprien, Falcone Guido, Huo Shufan, Clocchiatti-tuozzo Santiago, Renedo Daniela, Sharma Richa, Payabvash Sam, Sansing Lauren, Rangaraju Srikant, Sheth Kevin

Integrated Genomic and Proteomic Drug Target Discovery for Ischemic Stroke

Huo Shufan, Clocchiatti-tuozzo Santiago, Magid-bernstein Jessica, Sharma Richa, Rangaraju Srikant, Sansing Lauren, Sheth Kevin, Rivier Cyprien, Falcone Guido

You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.


   Rate this abstract  (Maximum characters: 500)